The Sino-French biomedicine investment forum
发布时间： 2017-08-13 19:38:27 浏览次数：
In order to promote biomedical and medical technology innovation, research and international exchanges and cooperation of industrialization, Sino-French bio-pharmaceutical industry has developed rapidly and the investment cooperation is becoming increasingly close. On May 18-21, 2017, Zhang Yuzhong, deputy director of the Investment Promotion Bureau of the Ministry of Commerce of the People's Republic of China, led a delegation of Chinese biomedical investors to visit the French counterpart. Commissioned by him, the French Deloitte & Touche and the Europe-China Investment Association jointly organized the Sino-French bio-medicine investment forum with the theme of " Sino-French cooperation and win-win in the field of biomedical cooperation ".
More than 100 people were invited, including the Chinese Ministry of Commerce Investment Promotion Bureau Deputy Director Zhang Yuzhong, the Chinese Embassy Economicand Commercial Counselor Division in France First Secretary Xiao Guofeng, France Governor of the province high France Eugene JOHNSON, Paris thirteenth district deputy mayor and councilor Chen Wenxiong, Villejuif mayor adviser Jean-François HAREL, France National Silver Economic Association Director-General Catherine MARCADIER SAFLIX, Vice-President of the CDC International Capital Investment Company Phllippe PRONOST, Deloitte & Touche Charles BEDIER, and the Europe-China Investment Association Chairman Li Yonggang and so on.
The guests of the forum
The seminar was held by Charles BEDIER, and Zhang Yuzhong introduced the work done by the Investment Promotion Bureau of the Ministry of Commerce in recent years to promote the two-way investment between China and France and looked forward to the Sino-French cooperation in the biomedical health industry.
Subsequently, Xiao Guofeng introduced the 2016 Sino-French Economic and Trade Committee during the 24th meeting, and stressed that the Chinese Embassy in France will promote the Sino-French cooperation in the silver economy together with the UN.
Chen Wenxiong said in recent years, Sino-French cooperation enjoyed a steady and rapid development, and hoped that Chinese and French biomedical enterprises could cooperate in more and more fields.
MARCADIER SAFLIX Introduced the advantages in development of French silver economy and foreign cooperation.
Ludovic GUILLAUME, Director of Asian Development for Orpéa, France's second largest pension group, also shared the development of the Orpéa Group in the Chinese market.
And then by the Weihai City Investment Promotion Center European Minister Song Yifeng and Weihai Economic and Technological Development Zone Commercial Bureau Chief Section Sun Ping, especially medical equipment and biomedical industrial park were introduced. They also introduced the development of the local park status, advantages and cooperation needs of France.
Then, five French and Chinese guests attending the forum held a roundtable dialogue on "Sino-French cooperation in biomedicalcooperation", including:
• Charles BEDIER ;
• Michel COLOMBIER, founder of ASTON MEDICAL orthopedic implants;
• Gérard HERMANT, Director-General of the Association for the Preservation of Elderly Care Services, and General Manager of the French Elite School of Psychology and Rehabilitation;
• Li Yonggang, Chairman of the Europe-China Investment Association;
• Wang Yongjiang,Director of Investment Promotion Bureau of Tianjin Development Zone.
The roundtable dialogue
In the roundtable dialogue, Li Yonggang introduced the trend of Sino-French development in cooperation, and elaborated on how to achieve win-win cooperation in the field of biomedicine.
Charles BEDIER said that there is a wide range of investment opportunities in the field of biomedical health, Deloitte & Touch committed to carry out equity cooperation in the Sino-French enterprises and to provide a comprehensive professional services.
After the meeting, the participants of the Sino-French guests were on the free exchange. Under the organization of Europe-China Investment Association, the French innovation enterprise Devinnova wearing ECG monitor company general manager Fabrice VAUSSENAT with a product prototype communicated with Lu Guangjun, General Manager of Beijing An Shun; Lyon Center Hospital Director Daniel FLAMMANG and the Ministry of Commerce Investment Promotion Bureau of the Ministry of Biomedical Industry, Deputy Director Jiao Wei discussed the introduction of syncope into China.
Daniel FLAMMANG and Jiao Wei
The successful activities promoted the Sino-French medicine health industry exchanges, the exploration of the two sides of the market opportunities, the integration of the two countries biomedical industry and has played a role in the joint efforts of China and France to a wider range of biomedical investment cooperation.
In the afternoon, the delegation also visited the largest "silver valley" pension industry cluster in the Paris region, and was warmly received by the cluster director Benjamin ZIMMER and the cluster of innovative entrepreneurs.